RecruitingNCT05763290

Childhood Cancer Survivors' Affective Response to Exercise


Sponsor

St. Jude Children's Research Hospital

Enrollment

125 participants

Start Date

Mar 22, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The primary objective of this study is to assess the feasibility of administering the Personalized Single-Category Implicit Association Test (PSC-IAT) to young adult survivors of childhood cancer. Participants will perform a total of three trials of a cognitive task before and after their scheduled SJLIFE cardiovascular stress testing. Participants will then be asked to participate in a qualitative interview about the cognitive task tool and body sensations and emotions experienced during exercise.


Eligibility

Min Age: 18 YearsMax Age: 39 Years

Inclusion Criteria5

  • Participants enrolled in St. Jude Lifetime Cohort (SJLIFE) aged 18-39 years at completion of on campus visit
  • Primary diagnosis of acute lymphoblastic leukemia (ALL)
  • No cranial radiation therapy (CRT) as part of treatment for ALL
  • Identify as physically inactive (do not meet Centers for Disease Control and Prevention (CDC) guidelines of 150 minutes of moderate physical activity per week or 75 minutes of vigorous physical activity per week)
  • Women who are not currently pregnant

Exclusion Criteria4

  • Individuals who cannot speak, read, and/or understand English.
  • Individuals with an estimated IQ of \<70 and/or per PI discretion
  • Individuals with any contraindication to stress testing (i.e. cardiovascular complications)
  • Women who are currently pregnant

Interventions

OTHERAffective Response to Exercise

Participants will perform a total of three trials of a cognitive task before and after their scheduled SJLIFE cardiovascular stress testing. Participants will then be asked to participate in a qualitative interview about the cognitive task tool and body sensations and emotions experienced during exercise.


Locations(1)

St. Jude Children's Research Hospital

Memphis, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05763290


Related Trials